Clinical Trial

An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate the efficacy and safety of an investigational ophthalmic solution in adults with ocular redness caused by minor eye irritations.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-06-11
Trial Details
NCT Number NCT07578363
Lead Sponsor Alcon Research
Conditions Ocular Hyperemia
Enrollment 178 participants
Start Date 2026-09
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-06-10